Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma

Por Vakkalanka, Bhanu, Link, Brian K.
Publicado em 2011

Monoclonal Antibodies in Lymphoma –the First Decade

Por Link, Brian K., Friedberg, Jonathan W.
Publicado em 2008

Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines

Por LINK, BRIAN K., BROOKS, JOHN, WRIGHT, KARA, PAN, XIAOYUN, VOELKER, MARGARET, CHRISCHILLES, ELIZABETH
Publicado em 2011

Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futile

Por Tien, Yu-Yu, Link, Brian K., Brooks, John M., Wright, Kara, Chrischilles, Elizabeth
Publicado no Leuk Lymphoma (2014)

Complement regulatory proteins CFHR1 and CFHR3 and patient response to anti-CD20 monoclonal antibody therapy

Por Rogers, Laura M., Mott, Sarah L., Smith, Brian J., Link, Brian K., Sahin, Deniz, Weiner, George J.
Publicado no Clin Cancer Res (2016)

Population-Based Exploration of Academic Achievement Outcomes in Pediatric Acute Lymphoblastic Leukemia Survivors

Por Harshman, Lyndsay A., Barron, Sheila, Button, Anna M., Smith, Brian J., Link, Brian K., Lynch, Charles F., Denburg, Natalie L.
Publicado em 2012

Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism

Por Veeramani, Suresh, Wang, Siao-Yi, Dahle, Christopher, Blackwell, Sue, Jacobus, Laura, Knutson, Tina, Button, Anna, Link, Brian K., Weiner, George J.
Publicado em 2011

FDG-PET Report Interpretation as Predictor of Outcome in Diffuse Large B-Cell Lymphoma Including Analysis of “Indeterminate” Reports

Por Thomas, Alexandra, Gingrich, Roger D., Smith, Brian J., Jacobus, Laura, Ristow, Kay, Allmer, Cristine, Maurer, Matthew J., Habermann, Thomas M., Link, Brian K.
Publicado em 2010

Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)

Por Wagner-Johnston, Nina D., Link, Brian K., Byrtek, Michelle, Dawson, Keith L., Hainsworth, John, Flowers, Christopher R., Friedberg, Jonathan W., Bartlett, Nancy L.
Publicado no Blood (2015)

Effectiveness of First-Line Management Strategies for Stage I Follicular Lymphoma: Analysis of the National LymphoCare Study

Por Friedberg, Jonathan W., Byrtek, Michelle, Link, Brian K., Flowers, Christopher, Taylor, Michael, Hainsworth, John, Cerhan, James R., Zelenetz, Andrew D., Hirata, Jamie, Miller, Thomas P.
Publicado em 2012

The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States

Por Nastoupil, Loretta J, Sinha, Rajni, Byrtek, Michelle, Zhou, Xiaolei, Taylor, Michael D, Friedberg, Jonathan W, Link, Brian K, Cerhan, James R, Dawson, Keith, Flowers, Christopher R
Publicado no Cancer (2014)

A Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following Rituximab Therapy of Follicular Lymphoma

Por Racila, Emilian, Link, Brian K., Weng, Wen-Kai, Witzig, Thomas E., Ansell, Stephen, Maurer, MatthewJ., Huang, Jian, Dahle, Christopher, Halwani, Ahmad, Levy, Ronald, Weiner, GeorgeJ.
Publicado em 2008

Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB...

Por Lin, Thomas S., Donohue, Kathleen A., Byrd, John C., Lucas, Margaret S., Hoke, Eva E., Bengtson, Elizabeth M., Rai, Kanti R., Atkins, James N., Link, Brian K., Larson, Richard A.
Publicado em 2010

Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy

Por Ammann, Eric M., Jones, Michael P., Link, Brian K., Carnahan, Ryan M., Winiecki, Scott K., Torner, James C., McDowell, Bradley D., Fireman, Bruce H., Chrischilles, Elizabeth A.
Publicado no Blood (2016)

Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States

Por Nabhan, Chadi, Byrtek, Michelle, Rai, Ashish, Dawson, Keith, Zhou, Xiaolei, Link, Brian K., Friedberg, Jonathan W., Zelenetz, Andrew D., Maurer, Matthew J., Cerhan, James R., Flowers, Christopher R.
Publicado no Br J Haematol (2015)

PROGNOSTIC SIGNIFICANCE OF PRETREATMENT SERUM CYTOKINES IN CLASSICAL HODGKIN LYMPHOMA

Por Marri, Preethi Reddy, Hodge, Lucy S., Maurer, Matthew J., Ziesmer, Steven C., Slager, Susan L., Habermann, Thomas M., Link, Brian K., Cerhan, James R., Novak, Anne J., Ansell, Stephen M.
Publicado em 2013

Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma

Por Thompson, Carrie A., Maurer, Matthew J., Cerhan, James R., Katzmann, Jerry A., Ansell, Stephen M., Habermann, Thomas M., Macon, William R., Weiner, George J., Link, Brian K., Witzig, Thomas E.
Publicado em 2011

Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab

Por Bowles, Julie A., Wang, Siao-Yi, Link, Brian K., Allan, Barrett, Beuerlein, Gregory, Campbell, Mary-Ann, Marquis, David, Ondek, Brian, Wooldridge, James E., Smith, Brian J., Breitmeyer, James B., Weiner, George J.
Publicado em 2006

Elevated Pretreatment Serum Levels of Interferon-inducible Protein-10 (CXCL10) Predict Disease Relapse and Prognosis in Diffuse Large B-Cell Lymphoma Patients

Por Ansell, Stephen M., Maurer, Matthew J., Ziesmer, Steven C., Slager, Susan L., Habermann, Thomas M., Link, Brian K., Witzig, Thomas E., Macon, William R., Dogan, Ahmet, Cerhan, James R., Novak, Anne J.
Publicado em 2012

A Phase I Clinical Trial of CpG Oligonucleotide 7909 (PF-03512676) in Patients with Previously Treated Chronic Lymphocytic Leukemia

Por Zent, Clive S., Smith, Brian J., Ballas, Zuhair K., Wooldridge, James E., Link, Brian K., Call, Timothy G., Shanafelt, Tait D., Bowen, Deborah A., Kay, Neil E., Witzig, Thomas E., Weiner, George J.
Publicado em 2011